ALPHA PHARMACEUTICALS PHARMA LTD
Opportunity 70/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (58/100).
Data confidence
Overall: low (54/100)Sparse data coverage. Treat AI-generated outputs as preliminary. Manual diligence essential.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (10 events)Click to expand
- 2026-01-12📄change-account-reference-date-company-previous-extendedaccounts · AA01
- 2025-12-30📄termination-director-company-with-name-termination-dateofficers · TM01
- 2025-12-09➖BARAKZAHI, Mohamed Mostafa resigneddirector
- 2025-08-08📄change-account-reference-date-company-current-shortenedaccounts · AA01
- 2025-07-31➕BARAKZAHI, Mohamed Mostafa appointeddirector
- 2025-07-31📄appoint-person-director-company-with-name-dateofficers · AP01
- 2025-07-31📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-01-08🏢Company incorporatedAs ALPHA PHARMACEUTICALS PHARMA LTD
- 2025-01-08➕PARSI, Amir Mehdy appointeddirector
- 2025-01-08📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 1.5 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanGroup structure
Alpha Pharmaceuticals Ltd holds 25-50% — a significant corporate investor but not a controlling parent.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Amir Mehdy Parsi Individual · British · DOB 07/1978 · age 48 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 08/01/2025 |
Alpha Pharmaceuticals Ltd Corporate entity | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 08/01/2025 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Retail · NN postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AFRO EXPRESS MART LIMITED→ 11389983 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| AGE UK NORTHAMPTONSHIRE TRADING LIMITED→ 02966624 · est 1994 · no financials extracted | — | — | — | — | 31y | — | — |
| ALDWINCLE STORES LIMITED→ 16989321 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ALIM FOOD LTD→ 15053033 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ALL 4U TRADING LTD→ 10371902 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| ALLSTEEL STORAGE LIMITED→ 08064916 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| ALMAANDCO LTD→ 15897183 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ALTURA SERVICE LIMITED→ 10104282 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| ALUMINIUM RAINFLOW LTD→ 11093108 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ALWAYS WELL LTD→ 09952626 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| AMADOS KOMMERS LTD→ 14098041 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AMAZE FINDS LTD→ 16801305 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 1 resigned)
Click a director name to see their full track record across all companies.